INS and type 2 diabetes mellitus: PCPRI has been reported to predict the requirement for multiple daily insulin injections in patients with T2DM and that this index was more useful for predicting treatment strategies such as oral anti-diabetic agents and insulin therapy than other C-peptide indices [37, 38].